Ownership history in Candriam S.C.A. · 24 quarters on record
This page tracks every 13F SEC filing in which Candriam S.C.A. reported a position in ACADIA PHARMACEUTICALS INC (ACAD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 537,601 | +131,850 | +32.5% | 0.06% | $11.5M | $21.34 |
| 2024 Q1 | ADDED | 405,751 | +175,334 | +76.1% | 0.05% | $7.5M | $18.49 |
| 2022 Q1 | REDUCED | 230,417 | -45,143 | -16.4% | 0.04% | $5.6M | $24.22 |
| 2021 Q4 | UNCHANGED | 275,560 | — | 0% | 0.04% | $6.4M | $23.34 |
| 2021 Q3 | UNCHANGED | 275,560 | — | 0% | 0.03% | $4.6M | $16.61 |
| 2021 Q2 | REDUCED | 275,560 | -23,328 | -7.8% | 0.05% | $6.7M | $24.39 |
| 2021 Q1 | UNCHANGED | 298,888 | — | 0% | 0.13% | $15.3M | $25.80 |
| 2020 Q4 | REDUCED | 298,888 | -10,112 | -3.3% | 0.13% | $16.0M | $53.46 |
| 2020 Q3 | ADDED | 309,000 | +70,000 | +29.3% | 0.12% | $12.7M | $41.25 |
| 2020 Q2 | ADDED | 239,000 | +159,000 | +198.8% | 0.12% | $11.6M | $48.47 |
As of 2025 Q4 — sorted by position size